These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15178915)

  • 1. A comparative study on the effects of naltrexone and loratadine on uremic pruritus.
    Legroux-Crespel E; Clèdes J; Misery L
    Dermatology; 2004; 208(4):326-30. PubMed ID: 15178915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
    Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
    J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
    Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
    J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L; Rachelska G; Nedelec B
    Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
    Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
    J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
    Pauli-Magnus C; Mikus G; Alscher DM; Kirschner T; Nagel W; Gugeler N; Risler T; Berger ED; Kuhlmann U; Mettang T
    J Am Soc Nephrol; 2000 Mar; 11(3):514-519. PubMed ID: 10703675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
    Metze D; Reimann S; Beissert S; Luger T
    J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
    Chen YC; Chiu WT; Wu MS
    Am J Kidney Dis; 2006 Jul; 48(1):69-76. PubMed ID: 16797388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of olopatadine hydrochloride on pruritus in skin diseases].
    Niide M; Okubo Y; Irisawa R; Tsuboi R
    Arerugi; 2006 Oct; 55(10):1327-36. PubMed ID: 17072113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.
    Carson KL; Tran TT; Cotton P; Sharara AI; Hunt CM
    Am J Gastroenterol; 1996 May; 91(5):1022-3. PubMed ID: 8633543
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
    Tamdee D; Charuluxananan S; Punjasawadwong Y; Tawichasri C; Patumanond J; Sriprajittichai P
    Anesth Analg; 2009 Nov; 109(5):1606-11. PubMed ID: 19843798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study.
    Szepietowski JC; Szepietowski T; Reich A
    Acta Dermatovenerol Croat; 2005; 13(2):97-103. PubMed ID: 16324422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
    Phan NQ; Bernhard JD; Luger TA; Ständer S
    J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory aquagenic pruritus with naltrexone.
    Ingber S; Cohen PD
    J Cutan Med Surg; 2005 Oct; 9(5):215-6. PubMed ID: 16502200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral naltrexone on pruritus in cholestatic patients.
    Mansour-Ghanaei F; Taheri A; Froutan H; Ghofrani H; Nasiri-Toosi M; Bagherzadeh AH; Farahvash MJ; Mirmomen S; Ebrahimi-Dariani N; Farhangi E; Pourrasouli Z
    World J Gastroenterol; 2006 Feb; 12(7):1125-8. PubMed ID: 16534857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.